Phase 3 β Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(22 sites)
Netherlands
Jeroen Bosch Hospital, 's-Hertogenbosch Meander Medical Center, Amersfoort Deventer Hospital, Deventer Catharina Hospital, Eindhoven Medisch Spectrum Twente, Enschede University Medical Center Groningen, Groningen Tjongerschans Hospital, Heerenveen Medical Center Leeuwarden, Leeuwarden Leiden University Medical Center, Leiden Maastricht UMC+, Maastricht Radboud University Medical Center, Nijmegen Erasmus MC University Medical Center, Rotterdam Maasstad Ziekenhuis, Rotterdam Regional Academic Center Utrecht, Antonius Hospital, Utrecht Norway
Oslo University Hospital, Oslo Sweden
Sahlgrenska University Hospital, Gothenburg SkΓ₯ne University Hospital, Lund Karolinska University Hospital, Stockholm